Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G for UTAH MEDICAL PRODUCTS INC Common Stock (UTMD).
- Disclosed ownership: 5.3%.
- Date of event: 30 Jun 2025.
BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G Report for UTAH MEDICAL PRODUCTS INC Common Stock (UTMD)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- UTMD
- Shares outstanding
- 3,258,189 shares
- Disclosed Ownership
- 172,684 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Jul 2025, 20:12:46 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 05 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 5.3% ownership in UTAH MEDICAL PRODUCTS INC Common Stock (UTMD) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 05 Feb 2025.
- Current filing was accepted on 17 Jul 2025, 20:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5.3% | 172,684 | 168,277 | 0 | Spencer Fleming | Managing Director |